St. John's wort promotes adipocyte differentiation and modulates NF-κB activation in 3T3-L1 cells

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 7, 2014, Pages 1132-1138

  Hatano, Tomoko ^a   Sameshima, Yuka ^a   Kawabata, Mami ^a   Yamada, Shizuo ^b   Shinozuka, Kazumasa ^a   Nakabayashi, Toshikatsu ^a   Mizuno, Hideya ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Adipocyte; Differentiation; Inflammation; Obesity; St. John's wort

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; HYPERICUM PERFORATUM EXTRACT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; PLANT EXTRACT;

ADIPOCYTE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; CELL STRAIN; CELL STRAIN 3T3 L1; CONTROLLED STUDY; DRUG EFFECT; MOUSE; NONHUMAN; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; 3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; FLOWER; HYPERICUM; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLIC SYNDROME X; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SURVIVAL; FLOWERS; HYPERICUM; METABOLIC SYNDROME X; MICE; NF-KAPPA B; PLANT EXTRACTS; PPAR GAMMA; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84904669363     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00989     Document Type: Article

References (34)

1. Salas-Salvadó J, Martinez-González MÁ, Bulló M, Ros E. The role of diet in the prevention of type 2 diabetes. Nutr. Metab. Cardiovasc. Dis., 21 (Suppl. 2), B32-B48 (2011).
2. Wilson PWF, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 112, 3066-3072 (2005).
3. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell, 87, 377-389 (1996).
4. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int. J. Obes. (Lond), 29, 146-150 (2005).
5. Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol., 288, H2031-H2041 (2005).
6. Sewter CP, Digby JE, Blows F, Prins J, O'Rahilly S. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J. Endocrinol., 163, 33-38 (1999).
7. Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol., 288, R1220-R1225 (2005).
8. Zoico E, Garbin U, Olioso D, Mazzali G, Fratta Pasini AM, Di Francesco V, Sepe A, Cominacini L, Zamboni M. The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: role of the NF-kappaB pathway. Int. J. Mol. Med., 24, 847-851 (2009).
9. Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NFkappa B transcription factor. Science, 242, 540-546 (1988).
10. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell, 84, 853-862 (1996).
11. Finco TS, Beg AA, Baldwin AS Jr. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. U.S.A., 91, 11884-11888 (1994).
12. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes, 55, 1537-1545 (2006).
13. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett., 580, 2917-2921 (2006).
14. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest., 116, 1784-1792 (2006).
15. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell, 79, 1147-1156 (1994).
16. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes, 52, 1655-1663 (2003).
17. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem., 276, 41245-41254 (2001).
18. Lawvere S, Mahoney MC. St. John's wort. Am. Fam. Physician, 72, 2249-2254 (2005).
19. Solomon D, Adams J, Graves N. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression. J. Affect. Disord., 148, 228-234 (2013).
20. +. J. Pharmacol. Exp. Ther., 290, 1363-1368 (1999).
21. Wonnemann M, Singer A, Müller WE. Inhibition of synaptosomal uptake of 3H- L -glutamate and 3H-GABA by hyperforin, a major constituent of St. John's wort: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmcology, 23, 188-197 (2000).
22. Amini Z, Boyd B, Doucet J, Ribnicky DM, Stephens JM. St. John's wort inhibits adipocyte differentiation and induces insulin resistance in adipocytes. Biochem. Biophys. Res. Commun., 388, 146-149 (2009).
23. Richard AJ, Amini ZJ, Ribnicky DM, Stephens JM. St. John's wort inhibits insulin signaling in murine and human adipocytes. Biochim. Biophys. Acta, 1822, 557-563 (2012).
24. Juman S, Yasui N, Okuda H, Ueda A, Negishi H, Miki T, Ikeda K. Caffeic acid phenethyl ester suppresses the production of adipocytokines, leptin, tumor necrosis factor-alpha and resistin, during differentiation to adipocytes in 3T3-L1 cells. Biol. Pharm. Bull., 34, 490-494 (2011).
25. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care, 16, 1167-1178 (1993).
26. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care, 24, 1069-1078 (2001).
27. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation, 102, 1296-1301 (2000).
28. Lira FS, Rosa JC, Pimentel GD, Seelaender M, Damaso AR, Oyama LM, do Nascimento CO. Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-κB pathway in 3T3-L1 adipocytes. Cytokine, 57, 98-106 (2012).
29. Müller WE. Current St John's wort research from mode of action to clinical efficacy. Pharmacol. Res., 47, 101-109 (2003).
30. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature, 395, 137-143 (1998).
31. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem., 270, 12953-12956 (1995).
32. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest., 101, 1354-1361 (1998).
33. Xiao Y, Yuan T, Yao W, Liao K. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway. FEBS J., 277, 687-696 (2010).
34. Shiota A, Shimabukuro M, Fukuda D, Soeki T, Sato H, Uematsu E, Hirata Y, Kurobe H, Sakaue H, Nakaya Y, Masuzaki H, Sata M. Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects. Eur. J. Pharmacol., 692, 84-90 (2012).